#WeWontRest is a Europe-wide campaign led by European Federation of Pharmaceutical Industries and Associations (EFPIA). Member associations like the ABPI and companies in 27 European countries; individuals and teams at all levels of the pharmaceutical industry across Europe are making pledges for how #WeWontRest in the fight against disease.
From General Managers to front-line scientists, the UK is proud to support the campaign and celebrated the passion, commitment and dedication of individuals, teams and companies in the pharmaceutical industry to discovering and developing new medicines for patients.
We’re telling our industry’s innovation story and using #WeWontRest to start the public discussion on the value of innovation, the value of medicines and the future of healthcare in Europe.
#WeWontRest until we manage to deliver solutions that make blood cancer a manageable of even curable condition.
#WeWontRest until we find ways to modify the course of Alzheimer's.
#WeWontRest until our regulatory work, in partnership with others, accelerates patient access to innovative medicines.
#WeWontRest until a cure for people living with Type 1 Diabetes is available.
#WeWontRest until cycling through treatments is no longer the norm for people with rheumatoid arthritis.
#WeWontRest until Multiple Sclerosis is no longer a life sentence.
#WeWontRest until patients have new treatment options to fight the world's deadliest diseases.
#WeWontRest until we solve the Alzheimer's puzzle.
Breakthroughs only come about because of the passion, commitment and dedication of individuals, teams and companies working to discover and develop new medicines for patients.
Read about the pledges industry experts have made to help make the world a healthier place.
VIEW THE PLEDGE WALL